Company intelligence / Profile preview
Genascence Corporation
Palo Alto, California, United Statesgenascence.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
GNSC-001 is currently in Phase 1b clinical trials for knee osteoarthritis. Pre-clinical studies showed a single treatment lasted beyond one year and improved both symptoms and joint structure in a large animal model.
- Therapeutic areas
- Rheumatology
- Modalities
- Gene therapy
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
California Institute for Regenerative Medicine (funding partner)
Beyond the preview
Go deeper on Genascence Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genascence Corporation.